From: STAT3: Key targets of growth-promoting receptor positive breast cancer
Molecular typing (Molecular subtype) | Anti-breast Cancer Activity | Cell line | Corresponding inhibitor | Type of tumor Hallmarks | Target spot/signaling pathway | Refs. |
---|---|---|---|---|---|---|
HER2 | Inhibit high proliferative activity | Patient derived cell lines | 4-(tertbutyl)-N-carbamoylbenzamide | Sustaining proliferative signaling | HER2, Ras, STAT3, Ki67 | [83] |
HER2 | Inhibit high proliferative activity, Regulate the level of cell drug resistance | YMB-1, MDA-MB-453 | 5,15‐DPP | Sustaining proliferative signaling | PI3K/Akt/mTOR pathway, STAT3 pathway | [84] |
HER2, Luminal | Inhibit high proliferative activity, Induce apoptosis | SK-BR-3, T47D | Lapatinib, Canertinib, Afatinib | Sustaining proliferative signaling, Resisting cell death | ERK/MAPK, STAT3, CREB, p70 S6 kinase, IkBa, p38, JNK, STAT5 | [85] |
HER2 | Inhibit high proliferative activity, Induced invasion and metastasis | NMuMG | Ruxolitinib | Sustaining proliferative signaling, Activating invasion & metabolism | HER2, HOXB7, JAK/STAT pathway | [86] |
HER2, Luminal | Inhibit high proliferative activity | BT-474, SK-BR-3 | Penitrem A | Sustaining proliferative signaling, | BK Channels, p27, EGFR, HER2 Akt, STAT3 | [87] |
HER2 | Inhibit high proliferative activity, Induce apoptosis | LAM patient-derived 621–101 and 621–103 cells | Pyrotinib | Sustaining proliferative signaling, Resisting cell death | EGFR/STAT3/CD24 loop, TSC2 | [88] |
HER2 | Inhibit high proliferative activity | MDA-MB-468 | / | Sustaining proliferative signaling | STAT3, GLI1/tGLI1, R-Ras2, Cep70, UPF3A | [89] |
HER2 | Inhibit high proliferative activity, Promote tumor cell invasion and metastasis, Promote tumor-related angiogenesis, Promote tumor-related inflammation | SK-BR-3 | / | Sustaining proliferative signaling, Inducing or accessing vascular, Tumor promoting inflammation, Activating invasion & metabolism | IL-30, STAT3, STAT1, KISS1, CD11b, Gr1 | [90] |
HER2, Luminal | Inhibit high proliferative activity, Induce apoptosis | JIMT-1, T47D, MCF-7 | Sodium propionate | Sustaining proliferative signaling, Resisting cell death | JAK2/STAT3 Pathway, ROS, p38 MAPK | [91] |
HER2 | Inhibit high proliferative activity, Induce apoptosis | SK-BR-3 | Acetylshikonin | Sustaining proliferative signaling, Resisting cell death | Δ16HER2, DHFR, HER2, Src, STAT3, Caspase-3 | [92] |
HER2 | Inhibit high proliferative activity, Induce apoptosis, Enhance immune evasion | NT2.5 | Entinostat | Sustaining proliferative signaling, Resisting cell death, Avoiding immune destruction | STAT3 Pathway, NF-κB Pathway, IL-6, MIP2, TNF-α, GMCSF | [93] |
HER2, Luminal | Inhibit high proliferative activity, Induce apoptosis | BT-474 | Quercetin | Sustaining proliferative signaling, Resisting cell death | STAT3, MMP9, PRAP, Caspase-3, JAK1, BAX, Bcl-2 | [94] |
HER2, Luminal | Inhibit high proliferative activity, Induce apoptosis, Promote tumor cell invasion and metastasis | MCF-7 | FA modified NPs | Sustaining proliferative signaling, Activating invasion & metabolism, Inducing or accessing vascular | HER2, FR, CA15.3, VEGF, STAT3, TNF-α, IL-6, IL-1β, IL-2 | [95] |
HER2 | Inhibit high proliferative activity, Promote tumor-related inflammation | SUM149, SUM190 | Tocilizumab | Sustaining proliferative signaling, Tumor promoting inflammation | IL-6, IL-6R, STAT3, HER2 | [96] |
HER2 | Inhibit high proliferative activity, Promote tumor-related inflammation, Enhance immune evasion | SK-BR-3 | Tamoxifen, Stattic | Sustaining proliferative signaling, Tumor promoting inflammation, Avoiding immune destruction | CD206, CD45, JAK, STAT3, CCL5, TNF-α, PD-L1 | [97] |
HER2, Luminal | Inhibit high proliferative activity | SK-BR-3, MCF-7 | Melatonin | Sustaining proliferative signaling, Activating invasion & metabolism, | HER2/MAPK/ERK pathway, Rsk2, Creb, STAT3, cSrc, Fak, Pax, Fascin, actin polymerization | [98] |
HER2 | Inhibit high proliferative activity, Induce apoptosis, | SK-BR-3, BT-474 | Ibrutinib | Sustaining proliferative signaling, Resisting cell death | Caspase-3, Caspase-8, PRAP1, p21, STAT3 | [99] |
HER2 | Inhibit high proliferative activity, Induce apoptosis, Inducing tumor-related angiogenesis | / | / | Sustaining proliferative signaling, Resisting cell death, Inducing or accessing vascular | Hippo pathways, PIK3CAH1047R, eIF4G, STAT3, MAPK, Akt, YAP, BCL-2 | [100] |
HER2 | Inhibit high proliferative activity, Regulate the level of cell drug resistance | SK-BR-3, JIMT-1, HCC1954, AU565 | Lapatinib, EDI3 siRNA | Sustaining proliferative signaling, | PI3K/Akt/mTOR pathway, GSK3β, EDI3, HER2, HIF1α, CREB, STAT3 | [101] |
HER2 | Inhibit high proliferative activity, Regulate the level of cell drug resistance, Enhance immune evasion, Induce apoptosis, Avoid cell aging | SK-BR-3, MDA-MB-468, HCC1419 | CD4 + Th1 cell, TNF-α, IFN-γ | Sustaining proliferative signaling, Resisting cell death, Tumor promoting inflammation, Senescent cells | p15INK4a, p15INK4b, EGFR, HER2, HER3, IFN-γRα, TNF-R1, Caspase-3, STAT1, STAT3, JAK1, JAK2, p38 MAPK | [102] |
HER2, Luminal | Inhibit high proliferative activity, Induce apoptosis, Promote epigenetic modification | AU565, MCF-7 | Trastuzumab, Neratinib, Stattic, Niclosamide | Sustaining proliferative signaling, Resisting cell death, Non-mutational epigenetic reprogramming | TRIM21, HER2, HER3, STAT3, ERK, Akt, p-53, FOXO3a | [103] |
HER2 | Inhibit high proliferative activity, Regulate the level of cell drug resistance | MDA-MB-453, BT-474, MCF-7/HER2 | catecholamine | Sustaining proliferative signaling, | PI3K/Akt/mTOR pathway, β2-AR, miR-21, MUC-1, HER2, STAT3, miR-199a/b-3p | [104] |
HER2 | Inhibit high proliferative activity, Regulate the level of cell drug resistance, Induce apoptosis, Promote epigenetic modification | SK-BR-3, BT-474 | siNCAPG | Sustaining proliferative signaling, Resisting cell death, Non-mutational epigenetic reprogramming | NCAPG, Src, STAT3, Cyclin D1, BCL-2 | [105] |
HER2 | Inhibit high proliferative activity, Promote epigenetic modification | T47D, SUM190 | / | Sustaining proliferative signaling, Non-mutational epigenetic reprogramming | Nectin-4, ErbB2, ErbB2, p95-ErbB2, ErbB2ΔEx16, JAK/STAT3 pathway, PI3K/Akt pathway | [106] |
HER2 | Inhibit high proliferative activity, Regulate the level of cell drug resistance | SK-BR-3 | siHES-1, siHIF1α | Sustaining proliferative signaling, | HIF1α, HES-1, STAT3, HER2, Akt, PTEN, p27, Cyclin D, JAK2 | [107] |
HER2 | Inhibit high proliferative activity, Regulate the level of cell drug resistance | SK-BR-3 | siIL-6, siSTAT3, | Sustaining proliferative signaling, Unlocking phenotypic plasticity | IL-6, STAT3 | [108] |
HER2 | Inhibit high proliferative activity, Promote tumor-related inflammation | Cell from PDXs | / | Sustaining proliferative signaling, Tumor promoting inflammation, | IL-6, STAT3 | [109] |
HER2 | Inhibit high proliferative activity, Regulate the level of cell drug resistance, Promote tumor-related angiogenesis, Promote tumor-related inflammation | SK-BR-3, BT-474, HCC1954 | Ponatinib, Sunitinib | Sustaining proliferative signaling, Tumor promoting inflammation, Inducing or accessing vascular | PDGFRA, PDGBRB, STAT3, ERK, IL-6 | [110] |
HER2 | Inhibit high proliferative activity, Regulate the level of cell drug resistance, Promote tumor cell invasion and metastasis, Maintain the dry level of tumor stem cells | BT-474, MDA-MB-468 | Ruxolitinib, Pacritinib, Vismodegib,Sonidegib | Sustaining proliferative signaling, Activating invasion & metabolism, unlocking phenotypic plasticity | JAK2/STAT3 pathway, SMO/GLI1/tGLI1 pathway, VEGF, CD44, CD24, CD31, BCL-2, Nanog, Ki-67 | [111] |
HER2 | Inhibit high proliferative activity, Regulate the level of cell drug resistance, Induce apoptosis | SK-BR-3 | Mycophenolic acid | Sustaining proliferative signaling, Resisting cell death, | Akt/FOXO1 pathway, JAK2/STAT3 pathway, PPAR, p-27, CyclinD1, Caspase-3, HER2, ERK | [112] |
HER2 | Inhibit high proliferative activity, Regulate the level of cell drug resistance | MDA-MB-468, AU565 | Ruxolitinib, Everolimus, Erlotinib | Sustaining proliferative signaling | BCL-2, BIRC8, Akt1, MAPK7, RPS6KA5, EGFR, HER2, JAK3, STAT3 | [113] |
HER2 | Inhibit high proliferative activity, Regulate the level of cell drug resistance | SK-BR-3, BT-474 | Ganetespib | Sustaining proliferative signaling | HER2, PI3K/Akt pathway, Ras/MEK/ERK pathway, STAT3, HER3, RGFR, Bcl-xl, Bcl-2, c-Myc, CyclinD1, CDK4 | [114] |
Luminal | Inhibit high proliferative activity, Regulate the level of cell drug resistance | MCF-7 | / | Sustaining proliferative signaling | FGFR/STAT3 pathway, Akt, HER2, gp130, ERK | [115] |
HER2 | Inhibit high proliferative activity, Regulate the level of cell drug resistance | BT-474, | / | Sustaining proliferative signaling | Caspae-3, STAT3, STAT3, STAT5, HER2, LIFR, HER3, EGFR, IL-6R, GM-CSFR, c-Myc | [116] |
HER2 | Inhibit high proliferative activity, Regulate the level of cell drug resistance, Promote tumor cell invasion and metastasis, Promote epigenetic reprogramming | HCC1954, SK-BR-3, JIMT-1, BT-474 | SNX631 | Sustaining proliferative signaling, Activating invasion & metabolism, Non-mutational epigenetic reprogramming | STAT1, STAT3, Akt, miR-21-3p, miR-21-5p, miR-221, BTG2, Ki-67, ARG1, Alpha-SMA | [117] |
HER2, Luminal | Inhibit high proliferative activity, Regulate the level of cell drug resistance | MDA-MB-453, HCC1954, MCF-7, T47D | / | Sustaining proliferative signaling | HER2, EGFR, Akt, Ki-67, Caspase-3, JAK2/STAT3 pathway | [118] |
HER2 | Inhibit high proliferative activity, Regulate the level of cell drug resistance, Promote tumor-related inflammation, | Cell fro PDXs | / | Sustaining proliferative signaling, Tumor promoting inflammation | Src/STAT3/ERK1/2 pathway, RGFR, IL-8, | [119] |
HER2 | Inhibit high proliferative activity, Regulate the level of cell drug resistance, Promote tumor-related inflammation | HME2-BM | Ruxolitinib, shSTAT3 | Sustaining proliferative signaling, Tumor promoting inflammation | STAT3, Akt, AkBa, IL-6, TG2 | [120] |
HER2 | Inhibit high proliferative activity, Regulate the level of cell drug resistance | EFM-192A, BT-474 | / | Sustaining proliferative signaling | Fibronectin, Snail, Occludin, E-Cadherin, HER2, ERK, Akt, STAT3 | [121] |
HER2 | Regulate the level of cell drug resistance, Induce apoptosis | SK-BR-3, BT-474, MDA-MB-453 | Lapatinib, S3I-201 | Resisting cell death | STAT3/Survivin pathway, PRAP, HER2 | [122] |
HER2 | Inhibit high proliferative activity, Regulate the level of cell drug resistance, Induce apoptosis | BT-474 | STAT3-decoy ODNs | Sustaining proliferative signaling, Resisting cell death | STAT3, Bcl-2, Mcl-1, Survivin, MUC4, Akt, Caspase-3, Cyto C | [123] |
Luminal | Inhibit high proliferative activity, Regulate the level of cell drug resistance, Controlled by genomic instability | MCF-7, BT-474, T47D | siAKTIP, siSGK3, siSTAT3, shAKTIP, siESR1, siCAND1, siFASN, siSUP7 | Sustaining proliferative signaling, Genome stability & mutation | AKTIP, ERα, S6, Akt, HOOK1, p70S6K, ERK2, SGK3, SERPINA3, STRADB, TFF1, GREB1, CCND1, NDUFB11, RPRD1B, RAB5B, PERP | [124] |
Luminal | Inhibit high proliferative activity, Promote tumor-related inflammation, Maintain the dry level of tumor stem cells, Promote epigenetic reprogramming | MCF-7, SUM159, HCC70 | shXIST | Sustaining proliferative signaling, Tumor promoting inflammation, Unlocking phenotypic plasticity, Non-mutational epigenetic reprogramming | XIST, ALDH, CD44, CD24, c-Myc, KLF4, SOX9, STAT3, IL-6, IL-8, miRNA let-7a, SOX2, NF-κB, IL-6R, ALDH1A1 | [125] |
Luminal | Inhibit high proliferative activity, Regulate the level of cell drug resistance, Induce apoptosis | BT-474, MCF-7 | siSTAT3, MID2-MT-OE | Sustaining proliferative signaling, Resisting cell death | STAT3, MID2, MROC4 | [126] |
Luminal | Inhibit high proliferative activity, Controlled by genomic instability, Enhance immune evasion, Promote tumor cell invasion and metastasis | MCF-7 | siSTAT3 | Sustaining proliferative signaling, Activating invasion & metabolism, Genome stability & mutation, Avoiding immune destruction | STAT3, PD-L1, STAT1, α-mannosidase II | [127] |
Luminal | Inhibit high proliferative activity | MCF-7 | / | Sustaining proliferative signaling | PTPN2, Akt, Met, ERK, STAT3, EGFR | [128] |
Luminal | Inhibit high proliferative activity, Promote tumor cell invasion and metastasis | MCF-7, T47D, BT-474 | shTBC1D9 | Sustaining proliferative signaling, Activating invasion & metabolism | TBC1D9, ARL8A, ARL8B, PLK1, HIF1α, STAT3, SPP1 | [129] |
Luminal | Inhibit high proliferative activity, Promote tumor cell invasion and metastasis, Promote tumor-related angiogenesis, Promote tumor-related inflammation | MCF-7, | shIL-8, siSTAT3 | Sustaining proliferative signaling, Activating invasion & metabolism, Tumor promoting inflammation, Inducing or accessing vascular | Leptin, IL-1β, IL-8, NF-κB p65, STAT3, Akt, Lin28B, EpCAM, N-Cadherin, Twist1, Snail, Vimentin, Ki-67, E-Cadherin, p16, JAK, ZEB1, CD44, CD24, p53, PCNA, CDKN2A, LEP, CXCL8, IL-6, RELA, miRNA Let-7b, HIF1α, VEGFA, mTOR, CD34 | [130] |
Luminal | Inhibit high proliferative activity, Promote tumor cell invasion and metastasis | MCF-7 | Diallyl Trisulfide | Sustaining proliferative signaling, Activating invasion & metabolism | STAT3, Bcl-2, Bcl-xl, Cyclin D1, VEGF, MMP2, MMP9 | [131] |
Luminal | Inhibit high proliferative activity, Promote tumor cell invasion and metastasis, Maintain the dry level of tumor stem cells, Promote epigenetic reprogramming | MCF-7 | siSTAT3 | Sustaining proliferative signaling, Activating invasion & metabolism, Tumor promoting inflammation, Unlocking phenotypic plasticity, | CD44, CD24, ALDH, STAT3, p16, IL-6, EpCAM, α-SMA, E-Cadherin, N-Cadherin, Vimentin, Akt, CD10, SOX2 | [132] |
Luminal | Inhibit high proliferative activity, Induce apoptosis | MCF-7 | Curcumin | Sustaining proliferative signaling, Resisting cell death | NF-κB, IκBα, p53, Bid, STAT3, Caspase-3. Caspase-8, Bax, c-Ha-Ras, Rho-A, Bcl-xl, CCND1 | [133] |
Luminal | Inhibit high proliferative activity, Controlled by genomic instability | SSM1, SSM2, SSM3 | / | Sustaining proliferative signaling, Genome stability & mutation | ERα, STAT1, STAT3, STAT5, PRLR, Rb, JAK2, KRAS | [134] |
Luminal | Inhibit high proliferative activity, Induce apoptosis, Maintain the dry level of tumor stem cells | / | / | Sustaining proliferative signaling, Resisting cell death, Unlocking phenotypic plasticity, | EGFR/STAT3 pathway, TGFB/TGF-β/SMAD pathway, ITGB1, CD29, ITGB1, CD61 | [135] |
Luminal | Inhibit high proliferative activity, Induce apoptosis, Maintain the dry level of tumor stem cells, Inducing normal cells to become cancerous by secreting aging phenotype | NBL-10, NBL-20, NBL-21, NBL-34 | / | Sustaining proliferative signaling, Resisting cell death, Senescent cells, Unlocking phenotypic plasticity | IL-6, IL-8, p16, p23, p51, Lamin B1, SA-β-gal, Ki-67, PCNA, GRO, GRO-α, IL-7, TIMP-1, TIMP-2, VEGF-A, Angiogenin, IL-7, LaminA, α-SMA, SDF-1, TGF-β1, Akt, ERK, STAT3, JAK, AUF1, E-Cadherin, EpCAM, N-Cadherin, Vimentin, Twist1, ZEB1, CD34, ALDH, CD24, CD44, HIF-1α, Bmi-1, SOX2, NANOG, OCT4, KLF4, ZEB1 | [136] |
Luminal | Inhibit high proliferative activity, Promote tumor cell invasion and metastasis | / | Losartan | Sustaining proliferative signaling, Activating invasion & metabolism | α-SMA, E-Cadherin, STAT3, VEGFA, F4/80, CD3, AGTR1, AT1R, TNF-α | [137] |
Luminal | Inhibit high proliferative activity, Promote tumor cell invasion and metastasis, Maintain the dry level of tumor stem cells | SUM149, SUM190 | Ruxolitinib, AZD1480, Solcitinib, Abrocitinib, Fedratinib, C188-9, SH-4–54 | Sustaining proliferative signaling, Activating invasion & metabolism, Unlocking phenotypic plasticity | cAMP/PKA pathway, JAK2/STAT3 pathway, CREB, CD44, CD24, STAT3, IL-6, EpCAM, E-cadherin, Vimentin, PDE4A | [138] |
Luminal | Inhibit high proliferative activity, Promote tumor cell invasion and metastasis, Maintain the dry level of tumor stem cells | MCF-7, T47D | siSTAT3, sip65, siCTRL | Sustaining proliferative signaling, Activating invasion & metabolism, Unlocking phenotypic plasticity | STAT3, STAT1, p65, IL-8, CXCL8, E-cadherin, CD44, CD24, PD-L1 | [139] |
Luminal | Inhibit high proliferative activity, Promote tumor cell invasion and metastasis, Maintain the dry level of tumor stem cells | Primary tumor cells | Stattic, LY-2157299 | Sustaining proliferative signaling, Activating invasion & metabolism, Unlocking phenotypic plasticity | EGFR/STAT3 pathway, TGF-β/SMAD payhway, CD61, CD29, ALDH, CD24, Ki-67, Vimentin, Twist1, E-Cadherin, Snail, Slug, JAK2, SOCS3, Pias3 | [140] |
Luminal | Regulate the level of cell drug resistanc, Promote tumor cell invasion and metastasis, Promote tumor-related inflammation | MCF-7, BT-474, T47D, ZR751 | shIL-6, | Activating invasion & metabolism, Tumor promoting inflammation | ERlo/Notchhi pathway, IL-6/STAT3 pathway, CD133, onco-miR-221, IL-6R, Vimentin, Fap, E-Cadherin, Fibronectin, Cavedin-1, ERα, Notch3, CD44 | [141] |
Luminal | Inhibit high proliferative activity, Induce apoptosis, Regulate the level of cell drug resistanc | MCF-7, T47D, TamR | Dasatinib, Stattic, siSTAT3 | Sustaining proliferative signaling, Resisting cell death | EGFR, STAT3, p21(Cip1), ERα, Akt, GSK3β, P70S6K, ERK, SRC, CyclinD1, Cyclin D3, Rb, PRAP, Survivin, LaminB1 | [142] |
Luminal | Inhibit high proliferative activity, Regulate the level of cell drug resistanc | TamS, TamR, MCF-7 | Akt IV, LY294002 | Sustaining proliferative signaling, | FN, JNK, STAT3, Akt, E-cadherin | [143] |
Luminal | Inhibit high proliferative activity, Promote tumor cell invasion and metastasis, Promote tumor-related inflammation | MCF-7, ZR75.30 | BAY 11–7085 | Sustaining proliferative signaling, Activating invasion & metabolism, Tumor promoting inflammation | NF-κB pathway, STAT3 pathway, VEGFR2 pathways, G-CSF, IL-8, IL-6, VEGF, VCAM-1, E-selectin, ICAM-1, IκBα, | [144] |
HER2 | Induce apoptosis | SK-BR-3 | miR-124 | Resisting cell death | STAT3, PRAP | [148] |
Luminal | Induce apoptosis, Promote epigenetic reprogramming | MCF-7 | siCBS, siCSE, | Resisting cell death, Non-mutational epigenetic reprogramming | miR-155/NOS2/NO pathway, H2S synthesizing enzymes, cystathionine b-synthase, cystathionine c-lyase, Akt, STAT3, ULPB2, MICA, IFN-β, TNF-α, CD80, CD86, 41BBL, HLA-DR, miR-4317 | [149] |
Luminal | Induce apoptosis, Promote tumor-related inflammation, Enhance immune evasion | SK-BR-3, | U0126, FcR | Resisting cell death, Tumor promoting inflammation, Avoiding immune destruction | MAPK pathway, IL-21R, STAT1, STAT3 | [150] |
Luminal | Induce apoptosis, Enhance immune evasion, Promote tumor cell invasion and metastasis, Promote tumor-related inflammation, Maintain the dry level of tumor stem cells | MCF-7, ZR751 | / | Resisting cell death, Activating invasion & metabolism, Tumor promoting inflammation, Avoiding immune destruction, Unlocking phenotypic plasticity | TNF-α, TNFAIP3, STAT3, PRAP1, Bcl-2, Bax, HSP70, STAT1, SOCS3, Vimentin, SNAIL, CDH1, CLDN3, IL-6, IL-8, CCL5, TFG-β, CD44, CD24, CD11b | [151] |
Luminal | Induce apoptosis, Enhance immune evasion, Controlled by genomic instability | T47D, MCF-7 | Alpelisib, CH5132799, LY255283, | Resisting cell death, Avoiding immune destruction, Genome stability & mutation, | PI3K/5-LOX/LTB4 pathway, CD33, CD8, Akt, STAT3, PKC, cPLA2, BLT2, NOX1, NOX4, IκBα, NF-κB, CD3 | [152] |
HER2 | Promote tumor cell invasion and metastasis, Maintain the dry level of tumor stem cells | SK-BR-3, BT20 | / | Activating invasion & metabolism, Unlocking phenotypic plasticity | JAK2/STAT3 pathway, TrkA, SOX2, Myc, ALDH, CD24, CD44 | [155] |
HER2, Luminal | Regulate the level of cell drug resistanc, Maintain the dry level of tumor stem cells, Promote tumor-related angiogenesis | MDA-MB-468, BT-474 | MEDI5117 | Unlocking phenotypic plasticity, Inducing or accessing vascular | IL-6, gp130, STAT3, PECAM-1, KDR, CD31, Ki-67, CD44, CD24, IL-8, TGF-β, IFN-γ | [156] |
Luminal | Maintain the dry level of tumor stem cells, Promote tumor cell invasion and metastasis, Promote tumor-related inflammation | 4T1 | Liposomal Nanoparticles Carrying anti-IL6R Antibody | Unlocking phenotypic plasticity, Activating invasion & metabolism, Tumor promoting inflammation, | IL-6/STAT3 pathway, CD44, SOX2, VEGFA, MMP9, CD206, IL-6R, CD31 | [157] |
HER2 | Promote tumor cell invasion and metastasis | SK-BR-3, BT-474 | shWASF3, siHER2, siHER3, Trastuzumab, AG490, S3I-201 | Activating invasion & metabolism | JAK2/STAT3 pathway, HER2, WASF3, HER3, HSP90, ZEB1 | [163] |
Luminal | Promote tumor cell invasion and metastasis, Regulating cell metabolism | T47D | / | Activating invasion & metabolism, regulating cellular metabolism | Akt, ATP7A, CCS, Complex IV Sub II, SOD1, Fibronectin, α-SMA, E-Cadherin, Vimentin, Vehicle, TRIEN, ERK, GSK3β, SMAD3, STAT3, TGF-β, LOXL2, MMP2, MMP9 | [164] |
Luminal | Promote tumor cell invasion and metastasis, Promote epigenetic reprogramming | MCF-7, T47D | Ruxolitinib | Activating invasion & metabolism, Non-mutational epigenetic reprogramming | ER, STAT3, PR, Ki67, IL-6, FOXA1 | [165] |
HER2 | Inhibit high proliferative activity, Regulate the level of cell drug resistance, Maintain the dry level of tumor stem cells, Promote tumor-related inflammation, | HCC1954 | IRAKi, Cisplatin, | Sustaining proliferative signaling, Unlocking phenotypic plasticity, Tumor promoting inflammation | CD44, CD24, CXCL1, CCL20, IL-1α, CXCL8, IL-6, IL-1β, STAT3, p65, IκB, ERK, Akt, NF-κB, STAT3m | [168] |
Luminal | Regulating cell senescence | NBL-10, NBL-34 | siSTAT3 | Senescent cells | E-Cadherin, EpCAM, N-Cadherin, Vimentin, Twist1, ZEB1, Snail, Slug, CD24, ALDH1/2, CD44, Bmi1, OCT4, KLF4, CD49, CK18, CK14, CD10, CD90, MUC-1, STAT3, AUF1, p16 | [181] |